France adds three to similar biologics list

Avastin (bevacizumab), Humalog (insulin lispro) and Herceptin (trastuzumab) have been added to France’s list of similar biologics as reference brands for newly-created similarity groups by local medicines agency ANSM. They add a further three groups to the 11 created when ANSM introduced the list last year (Generics bulletin, 10 November 2017, page 11), taking the full list to 14 reference groups covering 45 biosimilar brands.